PCN140 - The Expected Impact of Oncology Biosimilars In Brazil And Mexico: Payers and Oncologists Consider The cost-Effectiveness of These Cheaper Alternatives
| Autor: | Zevallos, S., Ribeiro, A., Cox, J. |
|---|---|
| Zdroj: | In Value in Health May 2015 18(3):A213-A213 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect